Hypoglycemia is common and dangerous in diabetes mellitus, so identifying at-risk patients may lead to useful preventive strategies. This Regenstrief-Merck partnership aims to design a risk calculator to aid clinicians in identifying at-risk patients who may benefit from preventive strategies. The project team members will conduct a retrospective cohort analysis, focus-group discussions, use of a new computer-based risk-prediction tool, and assessment of processes and outcomes associated with usage of the tool among healthcare providers.
In The NewsView All
LOINC® experts discussed their new collaboration with SNOMED CT, which enables those who use both standards to implement and operate them in a simple and efficient manner.Read More
‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia
Regenstrief Institute Research Scientist NiCole Keith, PhD, addressed the many...Read More
Featured FellowshipView all
- The Latest